Understanding Thyroid Blood Tests: TSH, T3, T4, Reverse T3 and Antibodies Explained

 

Quick Facts

•       The thyroid regulates metabolism, energy, temperature, mood, reproductive function and cognitive performance.

•       TSH is the standard first-line screening test, but a normal TSH does not rule out thyroid dysfunction.

•       Free T3 is the biologically active hormone; Free T4 is the precursor that must be converted in peripheral tissues.

•       Reverse T3 is an inactive form that competes with T3 at cellular receptors – elevated levels can produce hypothyroid symptoms with normal TSH and T4.

•       TPO antibodies are present in approximately 95% of Hashimoto’s thyroiditis cases – autoimmune activity can predate abnormal hormone levels by years.

•       NICE guideline NG145 (updated 2023) recommends measuring FT4 and FT3 together when TSH is below the reference range.

 

 

Thyroid disorders are among the most common endocrine conditions in the UK, particularly in women, yet thyroid dysfunction is also among the most frequently missed. In part this is because the symptoms – fatigue, brain fog, weight changes, low mood, hair thinning, poor recovery – overlap with so many other conditions. In part it is because standard testing is limited.

Many people are told their thyroid is ‘normal’ on the basis of a TSH alone.

That result is a start, not an answer.

TSH measures pituitary signalling, not thyroid hormone activity at the tissue level. Free T3, Free T4, conversion capacity, and antibody status are often equally or more important — and are frequently not measured.

This article explains what each thyroid marker actually measures, what patterns in results are clinically significant, and why interpreting them together – alongside symptoms – gives a substantially more useful picture than any single number in isolation.

 

 

The Role of the Thyroid Gland

 

The thyroid is a butterfly-shaped gland at the front of the neck that produces hormones regulating the metabolic rate of virtually every cell in the body.

When thyroid output is optimal, the effects are mostly invisible – the system works quietly in the background. When it is disrupted, the consequences are felt across multiple systems simultaneously.

Thyroid hormones govern energy production and metabolism, body temperature regulation, heart rate and cardiac output, cognitive performance and mood, gut motility and digestive function, menstrual regularity and fertility, hair, skin and nail integrity, and recovery from physical and psychological stress.

The thyroid does not operate independently. It is part of the hypothalamic-pituitary-thyroid (HPT) axis – a continuous feedback loop in which the hypothalamus releases thyrotropin-releasing hormone (TRH), which signals the pituitary to release thyroid-stimulating hormone (TSH), which in turn instructs the thyroid to produce T4 and T3. When circulating thyroid hormone levels are sufficient, TSH is suppressed. When they fall, TSH rises.

Understanding this feedback loop is essential for interpreting results – because a problem at any level of the axis, or in peripheral conversion of T4 to T3, can produce symptoms without producing an obviously abnormal TSH.

 

 

TSH – Thyroid-Stimulating Hormone

TSH is produced by the anterior pituitary gland and is the most sensitive indirect marker of thyroid hormone status available. It is appropriately used as the first-line screening test: NICE guideline NG145 (2023) endorses a cascading approach in which TSH is measured first, with Free T4 added if TSH is abnormal.¹

A raised TSH indicates the pituitary is working harder to stimulate a thyroid that is not producing sufficient hormone – consistent with hypothyroidism. A suppressed TSH indicates excess thyroid hormone is suppressing pituitary output – consistent with hyperthyroidism or over-treatment with levothyroxine.

However, TSH has significant limitations when used as a standalone assessment. It reflects average thyroid hormone levels over several weeks – it can appear normal while Free T3 is low, peripheral conversion is impaired, or autoimmune inflammation is actively damaging thyroid tissue. TSH is also a pituitary hormone: it measures downstream signalling rather than thyroid hormone availability at the cellular level.

Individual variation is clinically important. Population reference ranges for TSH are wide – typically 0.4 to 4.0 mIU/L – but each individual has their own set point within that range.

A TSH value of 3.8 mIU/L may be entirely normal for one person and represent relative hypothyroidism for another. This is why symptoms must always be considered alongside laboratory values, not used to override them.

 

 

T4 – Thyroxine

 

Thyroxine (T4) is the primary hormone secreted by the thyroid gland, accounting for approximately 80% of its total output. Despite being the dominant product of thyroid secretion, T4 functions primarily as a pro-hormone – it must be converted into triiodothyronine (T3) to exert most of its biological effects.

Approximately 80% of circulating T3 is derived from peripheral T4 conversion; only around 20% is directly secreted by the thyroid gland itself.²

 

Total T4 vs Free T4

 

Most T4 in the bloodstream is bound to transport proteins – principally thyroxine-binding globulin (TBG), transthyretin, and albumin – and is biologically inactive while bound. Only the unbound fraction, Free T4 (FT4), is available for cellular uptake and conversion.

Total T4 measures both bound and free hormone.

Binding protein levels change significantly in pregnancy, with oestrogen-containing contraceptives, in liver disease, and with a range of medications – all of which can alter Total T4 without reflecting any genuine change in thyroid function. For this reason, Free T4 is the clinically relevant measure in most contexts.

A low Free T4 alongside a raised TSH confirms hypothyroidism. A low Free T4 with a normal or low TSH should raise suspicion of secondary hypothyroidism – pituitary insufficiency rather than primary thyroid gland failure – which requires specialist investigation.

 

 

T3 – Triiodothyronine

 

T3 is the biologically active thyroid hormone. Its affinity for thyroid hormone receptors is approximately 15 times greater than T4, meaning T3 is the molecule that drives the metabolic and physiological effects attributed to thyroid function.³

It is produced predominantly through peripheral conversion of T4, via enzymes called deiodinases, primarily in the liver, kidneys, and skeletal muscle.

This dependence on conversion means that even with a fully functioning thyroid gland and normal T4 output, symptoms of hypothyroidism can occur if conversion is impaired. Common drivers of impaired conversion include chronic psychological stress, elevated cortisol, chronic inflammation, iron and selenium deficiency, significant caloric restriction, liver dysfunction, and certain medications.

 

 

Total T3 vs Free T3

 

As with T4, the majority of circulating T3 is bound to transport proteins. Total T3 measures both bound and free fractions and is subject to the same binding protein variability that limits Total T4.

Free T3 – the unbound, active fraction – is the more clinically informative measure.

A pattern of low or low-normal Free T3 with normal TSH and Free T4 is one of the most common and underappreciated presentations in thyroid medicine.

It indicates a conversion problem – adequate T4 is being produced, but its transformation into active T3 is being impaired. Standard NHS testing, which typically measures only TSH (and sometimes Free T4 if TSH is abnormal), will not detect this pattern.

 

 

Factors That Impair T4 to T3 Conversion

 

The following factors are recognised as clinically significant contributors to impaired peripheral T4 to T3 conversion. Where they are present alongside thyroid symptoms, measurement of Free T3 alongside Free T4 provides essential additional context.

 

Factor	Mechanism	Clinical Implication
Chronic Stress / Elevated Cortisol	Promotes type-3 deiodinase; shifts T4 toward rT3	Functional hypothyroidism with normal TSH and T4
Chronic Illness / Inflammation	Activates alternative deiodinase pathways	Euthyroid sick syndrome (non-thyroidal illness)
Significant caloric restriction	Reduces deiodinase enzyme activity	Lower T3, adaptive metabolic slowing
Iron deficiency	Cofactor for deiodinase enzymes	Reduced T4 to T3 conversion efficiency
Selenium deficiency	Required cofactor for selenoprotein deiodinases	Impaired conversion; reduced antioxidant protection of thyroid
Liver dysfunction	Primary site of peripheral T4 to T3 conversion	Reduced circulating T3 despite normal T4
Certain medications (amiodarone, beta-blockers, glucocorticoids)	Inhibit deiodinase activity	Lower Free T3 despite normal TSH and T4

 

 

 

Reverse T3 – The Inactive Competitor

 

When T4 is converted in peripheral tissues, it follows one of two pathways. Conversion via 5′-deiodinase (type 1 and type 2) produces active T3. Conversion via type-3 deiodinase produces reverse T3 (rT3) – a structurally similar but biologically inactive molecule. Critically, rT3 competes with active T3 at thyroid hormone receptors, occupying receptor sites without producing a biological effect and thereby reducing the effective activity of available T3.⁴

In healthy physiology, rT3 production is a normal regulatory mechanism – a controlled down-regulation of metabolism during periods of severe illness, prolonged fasting, or major physiological stress. The clinical problem arises when this pathway becomes chronically activated.

Research has established that in non-thyroidal illness syndrome (also called euthyroid sick syndrome) – a state seen in critical illness, chronic inflammatory disease, and sustained physiological stress – elevated rT3 with correspondingly low T3 is a defining biochemical feature.⁵

A 2025 review in PLOS One confirmed that T3 affinity for thyroid hormone receptors is approximately 15 times that of T4, and that rT3 inhibits thyroid hormone effects without binding to nuclear receptors, further reducing effective thyroid activity.³

 

 

The Clinical Debate Around Reverse T3

 

It is important to be accurate about where the clinical evidence stands. Reverse T3 is not part of standard NHS thyroid testing, and NICE NG145 does not recommend it as a routine marker. Its utility in defining treatment thresholds is not established in the same way as TSH or Free T4, and some endocrinologists remain sceptical of its clinical value outside of acute illness settings.

Where rT3 is most useful is as an explanatory marker in a specific clinical context: someone with persistent hypothyroid symptoms, normal TSH and Free T4, and evidence of chronic stress, inflammation, or significant lifestyle-related physiological load. In this context, an elevated rT3 alongside a low Free T3 – with a low Free T3:rT3 ratio – provides evidence of a conversion problem that standard testing cannot identify.

rT3 should always be interpreted alongside Free T3, Free T4, TSH, clinical symptoms, and contextual factors. It is not a standalone diagnostic marker and elevated levels do not, in isolation, confirm thyroid dysfunction.

 

 

Thyroid Antibodies – When the Immune System Is Involved

 

A substantial proportion of thyroid dysfunction in the UK is autoimmune in origin. Autoimmune thyroid disease (AITD) is the most common autoimmune condition globally, and the most prevalent endocrine autoimmune disorder, with a strong female preponderance.⁶

In the UK, Hashimoto’s thyroiditis is the leading cause of hypothyroidism; Graves’ disease is the leading cause of hyperthyroidism.

The key clinical feature of autoimmune thyroid disease is that immune-mediated thyroid damage can be active for years before TSH or free hormone levels move outside the laboratory reference range. Antibody testing is therefore not only relevant when hormone levels are abnormal – it is often most valuable in the period before they become so.

 

 

TPO Antibodies — Thyroid Peroxidase Antibodies

 

Thyroid peroxidase (TPO) is an enzyme essential to thyroid hormone synthesis. In Hashimoto’s thyroiditis, the immune system produces antibodies that target TPO, driving lymphocytic infiltration and progressive inflammatory destruction of thyroid tissue.

TPO antibodies are present in approximately 90–95% of people with Hashimoto’s thyroiditis, making anti-TPO the most sensitive available marker for autoimmune thyroid disease.⁷

They are also elevated in 60–80% of people with Graves’ disease, reflecting the breadth of the autoimmune process.

NICE NG145 recommends considering TPO antibody measurement in adults with TSH above the reference range, as antibody positivity is associated with progression to overt hypothyroidism and should inform the decision about whether to commence levothyroxine treatment.¹

Subclinical hypothyroidism with positive TPO antibodies carries a substantially higher risk of progression than subclinical hypothyroidism without them.

Importantly, TPO antibody positivity can occur with a TSH that remains within the reference range. These individuals often have symptoms, and some experience what is described as Hashimoto’s encephalopathy or thyroid-related mood disturbance — effects that appear to reflect direct immunological rather than purely hormonal mechanisms. Early identification allows for monitoring and timely intervention.

 

 

Thyroglobulin Antibodies — TgAb

 

Thyroglobulin is a protein produced exclusively by the thyroid gland as part of hormone synthesis. Thyroglobulin antibodies (TgAb) are elevated in a significant proportion of people with Hashimoto’s thyroiditis and are commonly measured alongside TPO antibodies to provide a fuller picture of autoimmune activity.

TgAb also has a specific and important role in thyroid cancer monitoring. After total thyroidectomy and radioactive iodine ablation, serum thyroglobulin should be undetectable. Rising TgAb in this context is a recognised marker of possible disease recurrence, even when thyroglobulin itself appears low – because antibodies can interfere with thyroglobulin immunoassays and produce falsely reassuring results.

 

TSH Receptor Antibodies — TRAb and Graves’ Disease

 

In Graves’ disease, the immune system produces antibodies that bind to and stimulate the TSH receptor on thyroid follicular cells – mimicking the action of TSH and driving unregulated, autonomous overproduction of thyroid hormones. These are called TSH receptor antibodies (TRAb) or, more specifically, thyroid-stimulating immunoglobulins (TSI).

TRAb are present in approximately 95% of people with Graves’ disease at diagnosis and are highly specific for the condition.⁸ A suppressed TSH with elevated Free T4 and Free T3, alongside positive TRAb, confirms Graves’ disease and distinguishes it from toxic nodular goitre and other causes of hyperthyroidism – a distinction that has direct treatment implications.

NICE NG145 recommends measuring Free T4 and Free T3 together when TSH is below the reference range, reflecting recognition that T3-dominant hyperthyroidism – where Free T3 is elevated disproportionately to Free T4 – is a distinct clinical pattern that would be missed by TSH and T4 measurement alone.¹

 

 

Why a Full Panel Matters – And What It Includes

 

The limitations of single-marker thyroid testing are not theoretical. They produce real clinical outcomes: people with significant hypothyroid symptoms dismissed on a normal TSH; autoimmune disease active for years before it is identified; conversion problems that explain persistent fatigue, brain fog, and poor recovery but are invisible to standard testing.

A comprehensive thyroid assessment should include TSH, Free T4, Free T3, TPO antibodies, and thyroglobulin antibodies as a baseline. Total T4 and Total T3 add limited information beyond their free fractions in most contexts. Reverse T3 adds value when chronic stress, systemic illness, or significant lifestyle factors are present alongside low Free T3.

Critically, results must be interpreted as a whole – in the context of symptoms, personal history, medication, and the relationships between markers – rather than as isolated numbers assessed against population reference ranges.

A Free T3 at the low end of the reference range in someone with fatigue, brain fog, and hair loss carries different clinical weight than the same value in someone who feels entirely well.

 

 

Frequently Asked Questions

Can I have a thyroid problem if my TSH is normal?

 

Yes. Normal TSH does not rule out thyroid dysfunction. Autoimmune thyroid disease can be active with normal TSH. Free T3 may be low due to impaired conversion. Symptoms and a fuller panel including Free T3, Free T4, and antibodies are required for a complete assessment.

 

 

What is the difference between Free T3 and Total T3?

 

Total T3 measures all circulating T3, including the majority bound to transport proteins. Free T3 measures only the unbound, biologically active fraction available to cells and tissues. Free T3 is the clinically relevant marker. Total T3 can be misleading when binding protein levels are altered by pregnancy, contraceptives, liver disease, or other factors.

 

 

What does it mean if I have high TPO antibodies but a normal TSH?

 

It means your immune system is targeting thyroid tissue, but the gland is still producing sufficient hormone to maintain normal TSH levels. This is an important finding. It confirms autoimmune thyroid disease — most commonly Hashimoto’s thyroiditis — and is associated with an increased risk of progression to overt hypothyroidism over time. Regular monitoring of TSH, symptoms, and antibody levels is warranted.

 

What causes elevated Reverse T3?

 

Elevated rT3 is most commonly driven by chronic psychological stress and elevated cortisol, chronic illness or systemic inflammation, significant caloric restriction, iron or selenium deficiency, liver dysfunction, and certain medications. It reflects the body’s adaptive downregulation of active thyroid hormone during periods of sustained physiological load.

 

 

Is Hashimoto’s thyroiditis the same as hypothyroidism?

 

No – they are related but distinct. Hashimoto’s is the autoimmune condition in which the immune system attacks the thyroid gland. Hypothyroidism is the functional consequence – insufficient thyroid hormone – that typically develops over time as a result of that damage. Someone can have active Hashimoto’s with normal hormone levels, particularly in the early stages. Not all hypothyroidism is caused by Hashimoto’s, and not all Hashimoto’s has yet produced hypothyroidism.

 

 

Should I test thyroid function privately if my GP has already tested me?

 

If only TSH was measured, you do not have a complete picture of your thyroid function. A comprehensive panel including Free T4, Free T3, TPO and thyroglobulin antibodies provides substantially more information – particularly if you have persistent symptoms despite a normal result. The decision to investigate further should be based on symptoms, not on reassurance from a single marker.

 

 

Final Thoughts

 

The thyroid is a system, not a number. TSH is a useful first signal – but it is the beginning of the investigation, not the conclusion. Free T3 tells you whether active hormone is reaching tissues. Free T4 tells you what the thyroid is producing. Reverse T3 tells you whether T4 is being converted into something useful or something that blocks cellular function. Antibodies tell you whether the immune system is part of the picture.

Each marker adds a dimension that the others cannot provide. Together, they explain why two people with identical TSH values can feel entirely different – and why symptoms should always be treated as clinically meaningful data alongside laboratory results.

Understanding your thyroid means understanding the whole system. A single normal result is not permission to stop looking.

 

 

 

REFERENCES

1. NICE Guideline NG145: Thyroid disease — assessment and management. Updated November 2023.

2. Clinical Evaluation of Various Thyroid Hormones on Thyroid Function. NCBI PMC, 2014.

3. Reverse T3 in patients with hypothyroidism on different thyroid hormone replacement. PLOS One, 2025.

4. Non-thyroidal illness (euthyroid sick) syndrome: Laboratory aspects and clinical significance. NCBI PMC, 2025.

5. Euthyroid sick syndrome — T3 reduction and rT3 elevation in critical illness. NCBI PMC, 2025.

6. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. NCBI PMC.

7. Mayo Clinic Laboratories: Thyroid Autoantibodies Profile — TPO antibody prevalence.

8. Cleveland Clinic: Thyroid Antibodies — TRAb in Graves’ disease.

9. Adapted Summary of UK Guidelines for Use of Thyroid Function Tests. NHS Lothian / Royal Liverpool.